vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»10.15690/vsp.v17i4.1929vsp-1933Research ArticleВ ПОМОЩЬ ВРАЧУA DOCTOR’S AIDСовременные представления о структурно-функциональных особенностях кожи, правилах ухода и профилактике дерматологической патологии у детей первого года жизниContemporary View of the Structural and Functional Peculiarities of the Skin, Items of Care and Prevention of Dermatological Pathology in Infantshttps://orcid.org/0000-0003-2252-8570МурашкинН. Н.MurashkinNikolay N.

Мурашкин Николай Николаевич, доктор медицинских наук, заведующий отделением дерматологии НМИЦ здоровья детей; профессор кафедры дерматовенерологии и косметологии ЦГМА; профессор кафедры педиатрии и детской ревматологии Первого МГМУ им. И.М. Сеченова

119991, Москва, Ломоносовский пр-т, д. 2, стр. 1

m_nn2001@mail.ruhttps://orcid.org/0000-0002-8232-8936АмбарчянЭ. Т.AmbarchianEduard Т.ЕпишевР. В.EpishevRoman V.https://orcid.org/0000-0002-6034-8231МатерикинА. И.MaterikinAlexander I.ФёдоровД. В.FedorovDmitriy V.Национальный медицинский исследовательский центр здоровья детей; Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет); Центральная государственная медицинская академияРоссияNational Medical Research Center of Children’s HealthRussian FederationНациональный медицинский исследовательский центр здоровья детейРоссияNational Medical Research Center of Children’s HealthRussian Federation201805102018174341345Copyright © Мурашкин Н.Н., Амбарчян Э.Т., Епишев Р.В., Материкин А.И., Фёдоров Д.В., 20182018Мурашкин Н.Н., Амбарчян Э.Т., Епишев Р.В., Материкин А.И., Фёдоров Д.В.Murashkin N.N., Ambarchian E.Т., Epishev R.V., Materikin A.I., Fedorov D.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1933

В статье представлены современные данные о структурных и функциональных особенностях кожного покрова у детей. Содержатся сведения об этиопатогенезе дебюта атопического дерматита. Представлены результаты собственных наблюдений с анализом клинической эффективности и безопасности косметических средств на основе высокоочищенного ланолина и экстракта хлопка у детей первого года жизни.

The article presents the modern knowledge of the structural and functional peculiarities of the skin in children. Information on the etiopathogenesis of a debut atopic dermatitis has been also given. The results of our own observations with an analysis of the clinical efficacy and safety of cosmetics based on highly purified lanolin and cotton extract in infants have been presented.

детиатопический дерматитпеленочный дерматитэмолентыэпидермальный барьермикробиомэкстракт хлопкаchildrenatopic dermatitisdiaper dermatitisemollientsepidermal barriermicrobiomecotton extractOOO «Зелдис-Фарма»Zeldis-Pharma LLCReferencesFluhr JW, Darlenski R, Lachmann N, et al. Infant epidermal skin physiology: adaptation after birth. Br J Dermatol. 2012;166(3): 483–490. doi: 10.1111/j.1365-2133.2011.10659.x.Fluhr JW, Darlenski R, Lachmann N, et al. Infant epidermal skin physiology: adaptation after birth. Br J Dermatol. 2012;166(3): 483–490. doi: 10.1111/j.1365-2133.2011.10659.x.Fluhr JW, Darlenski R, Taieb A, et al. Functional skin adaptation in infancy — almost complete but not fully competent. Exp Dermatol. 2010;19(6):483–492. doi: 10.1111/j.1600-0625.2009.01023.x.Fluhr JW, Darlenski R, Taieb A, et al. Functional skin adaptation in infancy — almost complete but not fully competent. Exp Dermatol. 2010;19(6):483–492. doi: 10.1111/j.1600-0625.2009.01023.x.Nikolovski J, Stamatas GN, Kollias N, Wiegand BC. Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life. J Invest Dermatol. 2008;128(7):1728–1736. doi: 10.1038/sj.jid.5701239.Nikolovski J, Stamatas GN, Kollias N, Wiegand BC. Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life. J Invest Dermatol. 2008;128(7):1728–1736. doi: 10.1038/sj.jid.5701239.Stamatas GN, Nikolovski J, Luedtke MA, et al. Infant skin microstructure assessed in vivo differs from adult skin in organization and at the cellular level. Pediatr Dermatol. 2010;27(2):125–131. doi: 10.1111/j.1525-1470.2009.00973.x.Stamatas GN, Nikolovski J, Luedtke MA, et al. Infant skin microstructure assessed in vivo differs from adult skin in organization and at the cellular level. Pediatr Dermatol. 2010;27(2):125–131. doi: 10.1111/j.1525-1470.2009.00973.x.Fluhr JW, Lachmann N, Baudouin C, et al. Development and organization of human stratum corneum after birth: electron microscopy isotropy score and immunocytochemical corneocyte labelling as epidermal maturation’s markers in infancy. Br J Dermatol. 2014;171(5):978–986. doi: 10.1111/bjd.12880.Fluhr JW, Lachmann N, Baudouin C, et al. Development and organization of human stratum corneum after birth: electron microscopy isotropy score and immunocytochemical corneocyte labelling as epidermal maturation’s markers in infancy. Br J Dermatol. 2014;171(5):978–986. doi: 10.1111/bjd.12880.Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int. 2013;62(2):151–161. doi: 10.2332/allergolint.13-RAI-0564.Leung DY. New insights into atopic dermatitis: role of skin barrier and immune dysregulation. Allergol Int. 2013;62(2):151–161. doi: 10.2332/allergolint.13-RAI-0564.Lund C. Issues in newborn skin care. Adv Neonatal Care. 2016;16(5):S1–S2. doi: 10.1097/Anc.0000000000000346.Lund C. Issues in newborn skin care. Adv Neonatal Care. 2016;16(5):S1–S2. doi: 10.1097/Anc.0000000000000346.Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242(1):233–246. doi: 10.1111/j.1600-065X.2011. 01027.x.Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev. 2011;242(1):233–246. doi: 10.1111/j.1600-065X.2011.01027.x.McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol. 2013;131(2):280–291. doi: 10.1016/j.jaci.2012.12.668.McAleer MA, Irvine AD. The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol. 2013;131(2):280–291. doi: 10.1016/j.jaci.2012.12.668.Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14): 1483–1494. doi: 10.1056/NEJMra074081.Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14): 1483–1494. doi: 10.1056/NEJMra074081.Ring J, Darsow U, Burgdorf WH, et al, editors. Braun-Falco Dermatologia. Lublin: Czelej; 2010. pp. 425–441.Ring J, Darsow U, Burgdorf WH, et al, editors. Braun-Falco Dermatologia. Lublin: Czelej; 2010. pp. 425–441.Peng W, Novak N. Pathogenesis of atopic dermatitis. Clin Exp Allergy. 2015;45(3):566–574. doi: 10.1111/cea.12495.Peng W, Novak N. Pathogenesis of atopic dermatitis. Clin Exp Allergy. 2015;45(3):566–574. doi: 10.1111/cea.12495.Pelc J, Czarnecka-Operacz M, Adamski Z. Structure and function of the epidermal barrier in patients with atopic dermatitis — treatment options. Part one. Postepy Dermatol Alergol. 2018;35(1):1–5. doi: 10.5114/ada.2018.73159.Pelc J, Czarnecka-Operacz M, Adamski Z. Structure and function of the epidermal barrier in patients with atopic dermatitis — treatment options. Part one. Postepy Dermatol Alergol. 2018;35(1):1–5. doi: 10.5114/ada.2018.73159.Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129(8): 1892–1908. doi: 10.1038/jid.2009.133.Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129(8): 1892–1908. doi: 10.1038/jid.2009.133.Fluhr JW, Behne MJ, Brown BE, et al. Stratum corneum acidification in neonatal skin: secretory phospholipase A2 and the sodium/ hydrogen antiporter-1 acidify neonatal rat stratum corneum. J Invest Dermatol. 2004;122(2):320–329. doi: 10.1046/j.0022202X.2003.00204.x.Fluhr JW, Behne MJ, Brown BE, et al. Stratum corneum acidification in neonatal skin: secretory phospholipase A2 and the sodium/ hydrogen antiporter-1 acidify neonatal rat stratum corneum. J Invest Dermatol. 2004;122(2):320–329. doi: 10.1046/j.0022202X.2003.00204.x.Ament W, Huizenga JR, Mook GA, et al. Lactate and ammonia concentration in blood and sweat during incremental cycle ergometer exercise. Int J Sports Med. 1997;18(1):35–39. doi: 10.1055/s-2007-972592.Ament W, Huizenga JR, Mook GA, et al. Lactate and ammonia concentration in blood and sweat during incremental cycle ergometer exercise. Int J Sports Med. 1997;18(1):35–39. doi: 10.1055/s-2007-972592.Thueson DO, Chan EK, Oechsli LM, Hahn GS. The roles of pH and concentration in lactic acid-induced stimulation of epidermal turnover. Dermatol Surg. 1998;24(6):641–645. doi: 10.1111/j.1524-4725.1998.tb04221.x.Thueson DO, Chan EK, Oechsli LM, Hahn GS. The roles of pH and concentration in lactic acid-induced stimulation of epidermal turnover. Dermatol Surg. 1998;24(6):641–645. doi: 10.1111/j.1524-4725.1998.tb04221.x.Eichenfield LF, Ellis CN, Mancini AJ, et al. Atopic dermatitis: epidemiology and pathogenesis update. Semin Cutan Med Surg. 2012;31(3 Suppl):S3–5. doi: 10.1016/j.sder.2012.07.002.Eichenfield LF, Ellis CN, Mancini AJ, et al. Atopic dermatitis: epidemiology and pathogenesis update. Semin Cutan Med Surg. 2012;31(3 Suppl):S3–5. doi: 10.1016/j.sder.2012.07.002.Zaniboni MC, Samorano LP, Orfali RL, Aoki V. Skin barrier in atopic dermatitis: beyond filaggrin. An Bras Dermatol. 2016;91(4): 472–478. doi: 10.1590/abd1806-4841.20164412.Zaniboni MC, Samorano LP, Orfali RL, Aoki V. Skin barrier in atopic dermatitis: beyond filaggrin. An Bras Dermatol. 2016;91(4): 472–478. doi: 10.1590/abd1806-4841.20164412.Pelc J, Czarnecka-Operacz M, Adamski Z. The structure and function of the epidermal barrier in patients with atopic dermatitis — treatment options. Part two. Postepy Dermatol Alergol. 2018;35(2):123–127. doi: 10.5114/ada.2018.75234.Pelc J, Czarnecka-Operacz M, Adamski Z. The structure and function of the epidermal barrier in patients with atopic dermatitis — treatment options. Part two. Postepy Dermatol Alergol. 2018;35(2):123–127. doi: 10.5114/ada.2018.75234.Trzeciak M, Glen J, Rebala K, et al. Coexistence of 2282del4 FLG gene mutation and IL-18 -137G/C gene polymorphism enhances the risk of atopic dermatitis. Postepy Dermatol Alergol. 2016;33(1): 57–62. doi: 10.5114/pdia.2015.48050.Trzeciak M, Glen J, Rebala K, et al. Coexistence of 2282del4 FLG gene mutation and IL-18 -137G/C gene polymorphism enhances the risk of atopic dermatitis. Postepy Dermatol Alergol. 2016;33(1): 57–62. doi: 10.5114/pdia.2015.48050.Filipowska-Gronska A, Werynska-Kalemba M, Bozek A, et al. The frequency of polymorphic variants of filaggrin gene and clinical atopic dermatitis. Postepy Dermatol Alergol. 2016;33(1):37–41. doi: 10.5114/pdia.2015.48036.Filipowska-Gronska A, Werynska-Kalemba M, Bozek A, et al. The frequency of polymorphic variants of filaggrin gene and clinical atopic dermatitis. Postepy Dermatol Alergol. 2016;33(1):37–41. doi: 10.5114/pdia.2015.48036.Miajlovic H, Fallon PG, Irvine AD, Foster TJ. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol. 2010;126(6): 1184–1190. doi: 10.1016/j.jaci.2010.09.015.Miajlovic H, Fallon PG, Irvine AD, Foster TJ. Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol. 2010;126(6): 1184–1190. doi: 10.1016/j.jaci.2010.09.015.Klunk C, Domingues E, Wiss K. An update on diaper dermatitis. Clin Dermatol. 2014;32(4):477–487. doi: 10.1016/j.clindermatol.2014.02.003.Klunk C, Domingues E, Wiss K. An update on diaper dermatitis. Clin Dermatol. 2014;32(4):477–487. doi: 10.1016/j.clindermatol.2014.02.003.Охлопков В.А., Зубарева Е.Ю., Новиков Ю.А., и др. Оценка клинической эффективности топической комбинированной терапии больных экземой, осложненной бактериальной инфекцией // Вестник дерматологии и венерологии. — 2014. — № 3 — С. 121–127.Klunk C, Domingues E, Wiss K. An update on diaper dermatitis. Clin Dermatol. 2014;32(4):477–487. doi: 10.1016/j.clindermatol.2014.02.003.Okhlopkov VA, Zubareva EYu, Novikov YuA, et al. Estimation of clinical efficiency of topical combination therapy patients with pyoderma complicated eczema. Vestn Dermatol Venerol. 2014;(3):121–127. (In Russ).Okhlopkov VA, Zubareva EYu, Novikov YuA, et al. Estimation of clinical efficiency of topical combination therapy patients with pyoderma complicated eczema. Vestn Dermatol Venerol. 2014;(3):121–127. (In Russ).Okhlopkov VA, Zubareva EYu, Novikov YuA, et al. Estimation of clinical efficiency of topical combination therapy patients with pyoderma complicated eczema. Vestn Dermatol Venerol. 2014;(3):121–127. (In Russ).Okhlopkov VA, Zubareva EYu, Novikov YuA, et al. Estimation of clinical efficiency of topical combination therapy patients with pyoderma complicated eczema. Vestn Dermatol Venerol. 2014;(3):121–127. (In Russ).

The authors declare that there are no conflicts of interest present.